Home/Filings/4/0001179110-19-002636
4//SEC Filing

Bracken Sharon J 4

Accession 0001179110-19-002636

CIK 0000001800other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 5:05 PM ET

Size

9.9 KB

Accession

0001179110-19-002636

Insider Transaction Report

Form 4
Period: 2019-02-22
Bracken Sharon J
Senior Vice President
Transactions
  • Award

    Common shares without par value

    2019-02-22+17,29256,321 total
  • Award

    Option (right to buy)

    2019-02-22+90,64290,642 total
    Exercise: $75.90From: 2020-02-22Exp: 2029-02-21Common shares (90,642 underlying)
Holdings
  • Common shares without par value

    (indirect: By Trust)
    760
Footnotes (3)
  • [F1]These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
  • [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 22, 2019.
  • [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,214 on February 22, 2020, 30,214 on February 22, 2021, and 30,214 on February 22, 2022.

Issuer

ABBOTT LABORATORIES

CIK 0000001800

Entity typeother

Related Parties

1
  • filerCIK 0001710778

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:05 PM ET
Size
9.9 KB